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Introduction 
Since few years, significant advances have been observed in the field of dioxins 
analysis. Many reports have been published conceming evolution in, not only sample 
preparation but also in the way in which resulting extracts are analyzed. The combined use 
of new extraction [I] and clean-up [2,3] techniques as well as last developments in the area 
of mass spectrometry [4] made it possible. However, most ofthe analytical procedures still 
include labor intensive sample preparation steps as well as high-cost equipment such as 
high resolution mass spectrometers (HRMS) only available in some well specialized 
laboratories and the overall process is both time and resource consuming. For these reasons, 
it is currently not yet possible to enlarge the analyses to sufficient number of samples in 
acceptable cost allowing early detection of contamination problems [5], In order to edge 
their way towards high sample throughput capabilities, analysis protocols have to be 
simplified. Efforts are then now more focused on development of alternative methods. In 
that field, the leading ideas are 1) fast, 2) screening and 3) low cost. 
As potential tools for screening method, biological assays (based on antibodies or cells 
response) attracted lot of attention during last few years with the emergence of a battery of 
bio and immuno-assays presenting advantages and drawbacks between them [6]. The mean 
appeal of these assays is not only the low cost (generally 5 times lower than classical 
HRMS) but also the possibility of parallel processing of samples. However, since the 
assays can also be activated by other chemicals present in the mixture in often higher 
concentration than analytes of interest, the sample preparation steps are still required to 
reduce the risks of false positives and they become the bottleneck ofthe procedure. These 
steps can often require several days of tedious work including delicate solvents exchanges 
due to the need of performing the assays in aqueous-type media [7]. In addition, depending 
on the considered assay, cross-reactivities (based on 2,3,7,8-TCDD) can be significantly 
different from a given TEF scale. Knowing that final TEQ estimation for many matrices 
mainly rest on the relative contribution of few congeners, these disparities regarding to the 
TEF can introduce uncertainties on the estimation. 
On the side of the development of these biological methods, advances in physico-
chemical analysis tools have also reach an interesting level [8]. This is worthwhile to 
evaluate their capabilities in term of screening for dioxins on a selected congeners basis [9]. 
Discussion 
From reviewing recent available literature concerning congeners distribution in food 
and human matrices, some tendencies can be outlined. It appears that for the hundreds of 
computed samples, 1,2,3,7,8-PeCDD and 2,3,4,7,8-PeCDF are the major contributors to the 
WHO-TEQ (Table 1). These relative contributions are quite constant over matrices types. 
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Table 1 : Relative contributions (%) of selected penta congeners. 
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[ 37-70 ] 
[ 45-78 ] 
11,22-37 
13,23,24,31,32,38 
n.a. ; not applicable due lo the limited sets of data available for congeners distribution 
The standard deviations are relatively low for all types of matrices, indicating that these 
contributions are representative of the general situation in good proportions. This 
observation has different consequences, I) it is of prime necessity for a screening tool to be 
able to consider these two congeners as accurately as possible, 2) these two congeners can 
be use as "screening congeners" for first sorting out of samples before relevant HRMS 
analysis. Since biological tools sometimes have relative response factors (especially for 
these two congeners) which does not match with the WHO-TEF values [39] and that these 
assays only give a global response, another tool would be appropriate. Knowing that even 
for assays, relevant clean-up methodology is required, it is quite conceivable to use GC to 
separate the congeners of interest and MS sensitive detector for screening. Recent 
improvement in the quadrupole ion storage tandem mass spectrometers (QISTMS) 
sensitivity present them as valuable detector [40,41,42]. They are easy to operate, their cost 
is acceptable, they have low picogram detection limits in isotopic dilution mode and they 
permit recovery rates calculations without any standards compatibility problems. Using 
adequate parameters and after time compression ofthe GC run, analyses can be carried out 
very rapidly. Fig. 1 illustrates an example of fast run (cycle time of less than 10 min) 
obtained with a benchtop ion trap mass spectrometer coupled to a classical GC system 
(A: 1,2,3,7,8-PeCDF, B:2,3,4,7,8-PeCDF, C: 1,2,3,7,8-PeCDD). 
In order to avoid false-negative production, a safe screening condition is to use the 
mean value for the sum of the two PeCDD/Fs as representative value for each type of 
matrix with a confidence of 20 %. Calculations from the obtained quantities would then 
allow the evaluation ofthe total WHO-TEQ and eventually the complementary analysis on 
HRMS. A crucial point here is that the samples which need further injection in HRMS are 
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Fig. 1 : PeCDD/Fs (min) 
already available and does not require any additional 
preparation before injection, greatly improving the overall 
speed and cost of the process. Considering the global control 
of the screening approach, as in the case of assays [43], 
certain amount (10%) of declared negative samples can 
systematically be confirmed by HRMS. This approach is 
currently under investigations to evaluate its robustness and 
it's already clear that such a strategy would not yields to the 
production of greater amounts of false negatives than other 
screening processes. 
In addition to a fast GC-MS analysis time, automated 
clean-up allows the preparation of large number ofsamples in 
parallel in a short amount of time. The global process 
considering milk samples for example can be as fast as few 
hours for batches of 10 samples, also allowing isolation ofthe 
PCBs and persistent pesticides fractions. 
This clean-up step is ofcourse the key step on which efforts have to be made since most 
of the screening cost results of that, A promising altemative being for us the use of 
disposable solid phase extraction (SPE) pre-packed cartridges that can easily be combined 
to produce clean extracts [44], The optimization as well as the transposition of this to 
automated systems using the new 96-well SPE technology for high sample throughput 
preparation would then also really be adapted to micro-plates bio-assays screening 
capabilities for the analysis of many samples in parallel. 
Conclusions 
Screening capability is one of the most wanted criteria for large number samples 
analysis in order to reduce the time spent to process samples containing negligible analyte 
levels. However, since the analysis of trace levels of dioxins require complex clean-up 
procedure, high sample throughput biological tools are currently not exploited at their 
oprimum level. The production of such a number ofsamples has to include simple and/or 
automated processes which then produce extracts presenting levels of cleanness compatible 
with the GC. The approach suggested here rests on the screening out of negative samples, 
before expensive GC-HRMS analysis, using quantification of selected representative 
congeners isolated by automated clean-up and analyzed by FGC-QISTMS. This method is 
versatile, the "screening congeners" are still representative in different contamination types 
(TCDD can be added if necessary) and the correlation between their concentration and the 
TEQ is easier than in the case of marker PCBs analysis for dioxins levels evaluation. 
This strategy can be seen as a cost effective "dioxin-dedicated" physico-chemical 
screening method complementary to a powerful biological tool capable of estimating the 
total toxicity of complex mixtures of large numbers of different halogenated aromatic 
hydrocarbons contained in samples. 
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